Ginkgo Bioworks Stock: Bull vs. Bear [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
However, since its initial public offering in September 2021, the stock has plunged 95%. So far in 2024, Ginkgo's shares have fallen more than 60%. Can Ginkgo Bioworks stage a major comeback? Or is the stock likely to continue floundering? Two Motley Fool contributors make the bull and bear arguments for Ginkgo. Bull case: A growing number of programs and customers Adria Cimino Ginkgo Bioworks has built a cell engineering platform that's attracted a wide range of customers across industries. The company has seen the most growth, though, in the healthcare and food and agriculture businesses. In pharma and biotech, Ginkgo's number of active programs increased 20% in the first quarter from the year-earlier period. And in food and agriculture, the number climbed more than 50%. The company is working with some of these industries' biggest names, from Pfizer to Syngenta. Pfizer, for example, is using Gingko's platform for the discovery of mRNA molecules across its key research areas
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- BioBuilder Launches Skills Training Curriculum to Prepare Students for Careers in Biotechnology [Yahoo! Finance]Yahoo! Finance
- Nvidia's New Sales Booster: The Global Push for Domestic AI Champions [Yahoo! Finance]Yahoo! Finance
- After Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA) [Yahoo! Finance]Yahoo! Finance
- Should Shareholders Have Second Thoughts About A Pay Rise For Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) CEO This Year? [Yahoo! Finance]Yahoo! Finance
- Should You Buy the Dip on Ginkgo Bioworks Stock? [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 5/9/24 - In-Line
DNA
Sec Filings
- 6/21/24 - Form 144
- 6/20/24 - Form 144
- 6/18/24 - Form 144
- DNA's page on the SEC website